These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17047209)

  • 1. Sirolimus-eluting stents vs brachytherapy for restenosis.
    Alfonso F; Sabate M
    JAMA; 2006 Oct; 296(15):1837-8; author reply 1838. PubMed ID: 17047209
    [No Abstract]   [Full Text] [Related]  

  • 2. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
    Holmes DR; Teirstein P; Satler L; Sketch M; O'Malley J; Popma JJ; Kuntz RE; Fitzgerald PJ; Wang H; Caramanica E; Cohen SA;
    JAMA; 2006 Mar; 295(11):1264-73. PubMed ID: 16531619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel-eluting stents, brachytherapy, and in-stent restenosis.
    Kaneda H; Ako J
    JAMA; 2006 Oct; 296(15):1838; author reply 1838-9. PubMed ID: 17047211
    [No Abstract]   [Full Text] [Related]  

  • 5. Brachytherapy for in-stent restenosis: a distant second choice to drug-eluting stent placement.
    Mukherjee D; Moliterno DJ
    JAMA; 2006 Mar; 295(11):1307-9. PubMed ID: 16531620
    [No Abstract]   [Full Text] [Related]  

  • 6. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
    Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular brachytherapy vs. drug-eluting stents for the treatment of in-stent restenosis: the jury's still out.
    Waksman R
    Catheter Cardiovasc Interv; 2004 Jul; 62(3):290-1. PubMed ID: 15224291
    [No Abstract]   [Full Text] [Related]  

  • 8. Sirolimus eluting stent fracture following angioplasty of diffuse in-stent restenosis in the right coronary artery.
    Wilczynska J; Rdzanek A; Kochman J; Horszczaruk GJ; Pietrasik A; Opolski G
    Int J Cardiol; 2007 May; 118(1):126-7. PubMed ID: 16908080
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents.
    Gagnor A; Varbella F; Rubartelli P; Luceri S; Conte MR
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):201-4. PubMed ID: 18192816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
    Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
    Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
    Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
    JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus-eluting stents: does a great stent still need a good interventionalist?
    Carrozza JP
    J Am Coll Cardiol; 2004 Mar; 43(6):1116-7. PubMed ID: 15028376
    [No Abstract]   [Full Text] [Related]  

  • 13. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.
    Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J;
    J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
    Dibra A; Kastrati A; Mehilli J; Pache J; Schühlen H; von Beckerath N; Ulm K; Wessely R; Dirschinger J; Schömig A;
    N Engl J Med; 2005 Aug; 353(7):663-70. PubMed ID: 16105990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion.
    Takebayashi H; Kobayashi Y; Dangas G; Fujii K; Mintz GS; Stone GW; Moses JW; Leon MB
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):496-9. PubMed ID: 14624428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of Sirolimus Eluting stents in interventional cardiology.
    Di Mario C; Griffiths H; O'Rourke B; Kaddoura S
    Int J Cardiol; 2004 Jun; 95(2-3):117-21. PubMed ID: 15193808
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis.
    Kim YH; Lee BK; Park DW; Park KH; Choi BR; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Dec; 98(11):1451-4. PubMed ID: 17126648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is a Drug-Eluting Stent the Default Treatment Strategy for Drug-Eluting Stent Restenosis?
    Colombo A; Ruparelia N
    J Am Coll Cardiol; 2015 Jul; 66(1):34-6. PubMed ID: 26139055
    [No Abstract]   [Full Text] [Related]  

  • 19. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
    Windecker S; Remondino A; Eberli FR; Jüni P; Räber L; Wenaweser P; Togni M; Billinger M; Tüller D; Seiler C; Roffi M; Corti R; Sütsch G; Maier W; Lüscher T; Hess OM; Egger M; Meier B
    N Engl J Med; 2005 Aug; 353(7):653-62. PubMed ID: 16105989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis.
    Saia F; Lemos PA; Hoye A; Sianos G; Arampatzis CA; de Feyter PJ; van der Giessen WJ; Smits PC; van Domburg RT; Serruys PW
    Catheter Cardiovasc Interv; 2004 Jul; 62(3):283-8. PubMed ID: 15224289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.